Chemotherapy

Cancer treatment cannot be left waiting for indefinite answers.

A denial or delay in authorizing chemotherapy and antineoplastic medications can directly affect the patient's treatment plan.

Issues involving high-cost medications, treatments not expressly included in the list of the ANS (Brazil's private health insurance regulator) or disagreements over therapeutic protocols require legal analysis grounded in medical, scientific and regulatory criteria.

Has your cancer treatment been denied or is it awaiting authorization? Seek legal guidance on your case.